Search Results - "Scherbakovsky S"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.

    Authors: Landry G Sulkowski M Feld JJ et al.

    Source: Viruses [Viruses] 2026 Feb 21; Vol. 18 (2). Date of Electronic Publication: 2026 Feb 21.

    Publication Type: Journal Article

    Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C.

    Authors: Buti M Drenth JPH Mendizabal M et al.

    Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2025 Oct; Vol. 45 (10), pp. e70275.

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE

    Save to List
  3. 3

    The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.

    Authors: Jacobson IM Bourgeois S Mathurin P et al.

    Source: Journal of viral hepatitis [J Viral Hepat] 2023 May; Vol. 30 (5), pp. 448-454. Date of Electronic Publication: 2023 Mar 02.

    Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2893 (Electronic) Linking ISSN: 13520504 NLM ISO Abbreviation: J Viral Hepat Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.

    Authors: Sulkowski M Telep LE Colombo M et al.

    Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 May; Vol. 55 (9), pp. 1169-1178. Date of Electronic Publication: 2022 Mar 02.

    Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.

    Authors: Flamm S Lawitz E Borg B et al.

    Source: Viruses [Viruses] 2023 Sep 29; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 29.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List

Search Tools: